Please ensure Javascript is enabled for purposes of website accessibility

B.Braun to expand local IV therapy manufacturing facility

Part of what B. Braun is calling the “Solutions for Life” initiative, the investments aim to help prevent IV fluid shortages in the United States.

“IV fluids are a fundamental component of patient care to hydrate patients, administer drugs and replace lost blood volume,” Dr. Maria Angela Karpf, corporate vice president for B. Braun Medical Inc., said in a statement.

“In recent years, the U.S. market has seen destructive weather events and severe influenza seasons contributing to major nationwide IV fluid shortages. These shortages forced health care professionals and facilities to delay patient treatments or use alternate techniques.”

Caroll H. Neubauer, CEO and chairman of B. Braun, announced the Solutions for Lifeinitiative May 14 at a stakeholder briefing and panel discussion in Washington, D.C., which included legislative leaders.

“IV fluid shortages have the potential to cause serious complications for patients across the country, particularly in times of public health emergencies,” said Pennsylvania Republican Sen. Pat Toomey. “B. Braun is making an important investment to address this concern by expanding production capacity and improving the ability to deliver IV fluids when and where they are needed.”

B. Braun Medical Inc. is part of the B. Braun Group of Companies, which includes B. Braun Interventional Systems, Aesculap and CAPS.

Globally, the B. Braun Group of Companies employs more than 63,000 employees in 64 countries.

Business Journal Events

Fastest Growing Companies Awards

Wednesday, October 20, 2021
Fastest Growing Companies Awards

Reader Rankings Awards

Monday, October 25, 2021
Reader Rankings Awards

Icon Honors

Thursday, November 04, 2021
Icon Honors

Best Places to Work in PA

Thursday, December 02, 2021
Best Places to Work in PA
/* code for sifitag */